Company Profile: Genzyme Corp. (NASDAQ:GENZ)
Rate:
24,602 ratings
Views: 598
From: TradeTheTrend
Added: 16 years ago · 0:58 · 480p
The company's product portfolio focuses on rare genetic disorders as well as kidney disease, cancer, and biosurgery. One of its ...
Comments
No comments yet.
